List of works - Saad S. Kenderian

Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

scientific article published on 13 December 2019

Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a 'graft versus host'-like syndrome and poor outcomes

scientific article published on 11 March 2020

Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist

scientific article published on 12 September 2014

CART Cell Toxicities: New Insight into Mechanisms and Management

scientific article published on 23 November 2020

CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia

scientific article

Characteristics of late transplant-associated thrombotic microangiopathy (TA-TMA) in patients who underwent allogeneic hematopoietic stem cell transplantation

scientific article published on 02 July 2020

Chimeric Antigen Receptor T Cells and Hematopoietic Cell Transplantation: How Not to Put the CART Before the Horse

scientific article published on 13 September 2016

Chimeric antigen receptor T-cell therapy to target hematologic malignancies

scientific article published on 4 November 2014

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation

scientific article published on 18 December 2018

Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms.

scientific article

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Tran

scientific article published on 15 May 2019

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies

scientific article

Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution

scientific article published on 2 February 2016

Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation

scientific article published on 26 October 2015

Monosomal karyotype in Philadelphia chromosome-negative acute lymphoblastic leukemia.

scientific article published on 5 July 2013

Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia

scientific article published on 21 April 2016

Ostomies in rectal cancer patients: what is their psychosocial impact?

scientific article published on 10 October 2013

Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice

scientific article published on 8 November 2016

Racial and sex differences in presentation and outcomes of small cell lung cancer in the United States: 1973 to 2010.

scientific article published in April 2015

The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma.

scientific article published on 27 January 2016

The Microbiome and Immune Regulation After Transplantation

scientific article

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice

scientific article published on 18 March 2020

Therapeutic options for patients with lymphoma and liver dysfunction or failure during mechlorethamine shortage

scientific article published on 31 December 2013

Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells.

scientific article published on 4 November 2015

List of works by Saad S. Kenderian

Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a 'graft versus host'-like syndrome and poor outcomes

Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist

CART Cell Toxicities: New Insight into Mechanisms and Management

CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia

Characteristics of late transplant-associated thrombotic microangiopathy (TA-TMA) in patients who underwent allogeneic hematopoietic stem cell transplantation

Chimeric Antigen Receptor T Cells and Hematopoietic Cell Transplantation: How Not to Put the CART Before the Horse

Chimeric antigen receptor T-cell therapy to target hematologic malignancies

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation

Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms.

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Tran

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies

Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution

Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation

Monosomal karyotype in Philadelphia chromosome-negative acute lymphoblastic leukemia.

Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia

Ostomies in rectal cancer patients: what is their psychosocial impact?

Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice

Racial and sex differences in presentation and outcomes of small cell lung cancer in the United States: 1973 to 2010.

The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma.

The Microbiome and Immune Regulation After Transplantation

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice

Therapeutic options for patients with lymphoma and liver dysfunction or failure during mechlorethamine shortage

Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells.